» Articles » PMID: 33663319

Critically Ill, Tubular Injury, Delayed Early Recovery: Characteristics of Acute Kidney Disease with Renal Oxalosis

Overview
Journal Ren Fail
Publisher Informa Healthcare
Date 2021 Mar 5
PMID 33663319
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objects: This study aimed to analyze the clinicopathological features of acute kidney disease (AKD) with renal oxalosis.

Methods: Data for biopsy-proven AKD with oxalosis diagnosed from Jan 2011 to Oct 2018 was collected. The underlying diseases, dietary habits, clinical and pathological characteristics of newly emerging kidney disease were analyzed. The long-term renal prognosis was observed.

Results: A total of 23 patients were included, comprised of 18 men and 5 women with a mean age of 51.6 ± 15.9 years. The peak Scr was 669.9 ± 299.8 μmol/L, and 95.7% of patients had stage 3 acute kidney injury (AKI). Drug-induced tubulointerstitial nephritis (TIN) was the most common cause (65.2%) of AKD, followed by severe nephrotic syndrome (17.4%). All patients had pathological changes indicating TIN, and 11 patients were complicated with the newly emerging glomerular disease (GD). The risk of oxalosis caused by increased enterogenous oxalate absorption accounted for only 26.1%, and others came from new kidney diseases. The majority (75%) of abundant (medium to severe) oxalosis occurred in patients without GD. There were no significant differences in the score for tubular injury (T-IS) and interstitial inflammation with different severities of oxalosis. Rate of Scr decrease (ΔScr%) at 2 weeks was negatively correlated with the severity of oxalosis ( = -0.542,  = 0.037), score for T-IS ( = -0.553,  = 0.033), and age ( = -0.736,  = 0.002). The decrease in Scr at 4 weeks was correlated with T-IS ( = -0.433), but had no correlation with oxalosis.

Conclusions: The present findings revealed that 95.7% of AKD with secondary renal oxalosis occurred in critically ill patients. AKD from tubular injury was the prominent cause. Severe oxalosis contributed to delayed early recovery of AKD.

Citing Articles

Determinants and impact of calcium oxalate crystal deposition on renal outcomes in acute kidney injury patients.

Yang W, Zhao T, Chen X, Wang S, Wang Y, Su T Ren Fail. 2024; 46(1):2334396.

PMID: 38570195 PMC: 10993744. DOI: 10.1080/0886022X.2024.2334396.


Hirsutidin Prevents Cisplatin-Evoked Renal Toxicity by Reducing Oxidative Stress/Inflammation and Restoring the Endogenous Enzymatic and Non-Enzymatic Level.

Imam F, Kothiyal P, Alshehri S, Afzal M, Iqbal M, Khan M Biomedicines. 2023; 11(3).

PMID: 36979784 PMC: 10045162. DOI: 10.3390/biomedicines11030804.


Rhabdomyolysis, myoglobinuric nephrosis, and crystalline nephropathy in a captive bottlenose dolphin.

Nueangphuet P, Hamano T, Hirai T, Sakaguchi Y, Sonoda H, Otsuka M J Vet Diagn Invest. 2022; 34(4):668-673.

PMID: 35477373 PMC: 9266508. DOI: 10.1177/10406387221090516.

References
1.
Ermer T, Eckardt K, Aronson P, Knauf F . Oxalate, inflammasome, and progression of kidney disease. Curr Opin Nephrol Hypertens. 2016; 25(4):363-71. PMC: 4891250. DOI: 10.1097/MNH.0000000000000229. View

2.
Efe O, Verma A, Waikar S . Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity. Curr Opin Nephrol Hypertens. 2019; 28(4):316-320. PMC: 6687319. DOI: 10.1097/MNH.0000000000000515. View

3.
Lumlertgul N, Siribamrungwong M, Jaber B, Susantitaphong P . Secondary Oxalate Nephropathy: A Systematic Review. Kidney Int Rep. 2018; 3(6):1363-1372. PMC: 6224620. DOI: 10.1016/j.ekir.2018.07.020. View

4.
Brzica H, Breljak D, Burckhardt B, Burckhardt G, Sabolic I . Oxalate: from the environment to kidney stones. Arh Hig Rada Toksikol. 2014; 64(4):609-30. DOI: 10.2478/10004-1254-64-2013-2428. View

5.
Getting J, Gregoire J, Phul A, Kasten M . Oxalate nephropathy due to 'juicing': case report and review. Am J Med. 2013; 126(9):768-72. DOI: 10.1016/j.amjmed.2013.03.019. View